Progress in Extracellular Vesicle Biology and Their Application in Cancer Medicine

Overview

Journal Wiley Interdiscip Rev Nanomed Nanobiotechnol

Specialty Biotechnology

Date 2020 Mar 5

PMID 32131140

Citations 32

Authors

Akhil Srivastava

Narsireddy Amreddy

Vipul Pareek

Mahendran Chinnappan

Rebaz Ahmed

Meghna Mehta

Mohammad Razaq

Anupama Munshi

Rajagopal Ramesh

Affiliations

Soon will be listed here.

Abstract

Under the broader category of extracellular vesicles (EVs), exosomes are now well recognized for their contribution and potential for biomedical research. During the last ten years, numerous technologies for purification and characterization of EVs have been developed. This enhanced knowledge has resulted in the development of novel applications of EVs. This review is an attempt to capture the exponential growth observed in EV science in the last decade and discuss the future potential to improve our understanding of EVs, develop technologies to overcome current limitations, and advance their utility for human benefit, especially in cancer medicine. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.

Citing Articles

miR-709 exerts an angiogenic effect through a FGF2 upregulation induced by a GSK3B downregulation.

Ueno K, Kurazumi H, Suzuki R, Yanagihara M, Mizoguchi T, Harada T Sci Rep. 2024; 14(1):11372.

PMID: 38762650 PMC: 11102560. DOI: 10.1038/s41598-024-62340-4.

Physio-chemical Modifications to Re-engineer Small Extracellular Vesicles for Targeted Anticancer Therapeutics Delivery and Imaging.

Asfiya R, Xu L, Paramanantham A, Kabytaev K, Chernatynskaya A, McCully G ACS Biomater Sci Eng. 2024; 10(2):697-722.

PMID: 38241003 PMC: 10956554. DOI: 10.1021/acsbiomaterials.3c01404.

Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems.

Wang Z, Wang X, Xu W, Li Y, Lai R, Qiu X Pharmaceutics. 2023; 15(11).

PMID: 38004601 PMC: 10674763. DOI: 10.3390/pharmaceutics15112623.

Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential.

Das K, Paul S, Ghosh A, Gupta S, Mukherjee T, Shankar P Cancers (Basel). 2023; 15(19).

PMID: 37835573 PMC: 10571545. DOI: 10.3390/cancers15194879.

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles.

Islam M, Khan M, Gidwani K, Witwer K, Lamminmaki U, Leivo J Biomark Res. 2023; 11(1):85.

PMID: 37773167 PMC: 10540341. DOI: 10.1186/s40364-023-00520-6.

References

Harding C, Heuser J, Stahl P . Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol. 1984; 35(2):256-63. View

Benz Jr E, Moses H . Small, virus-like particles detected in bovine sera by electron microscopy. J Natl Cancer Inst. 1974; 52(6):1931-4. DOI: 10.1093/jnci/52.6.1931. View

Wortzel I, Dror S, Kenific C, Lyden D . Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019; 49(3):347-360. DOI: 10.1016/j.devcel.2019.04.011. View

Wang M, Altinoglu S, Takeda Y, Xu Q . Integrating Protein Engineering and Bioorthogonal Click Conjugation for Extracellular Vesicle Modulation and Intracellular Delivery. PLoS One. 2015; 10(11):e0141860. PMC: 4631329. DOI: 10.1371/journal.pone.0141860. View

Takov K, Yellon D, Davidson S . Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential. J Extracell Vesicles. 2019; 8(1):1560809. PMC: 6327926. DOI: 10.1080/20013078.2018.1560809. View

Vella L . The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol. 2015; 4:361. PMC: 4271613. DOI: 10.3389/fonc.2014.00361. View

Castellanos-Rizaldos E, Zhang X, Tadigotla V, Grimm D, Karlovich C, Raez L . Exosome-based detection of activating and resistance mutations from plasma of non-small cell lung cancer patients. Oncotarget. 2019; 10(30):2911-2920. PMC: 6499599. DOI: 10.18632/oncotarget.26885. View

Bianchi F, Nicassio F, Marzi M, Belloni E, DallOlio V, Bernard L . A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med. 2011; 3(8):495-503. PMC: 3377091. DOI: 10.1002/emmm.201100154. View

Kosaka N, Iguchi H, Ochiya T . Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101(10):2087-92. PMC: 11159200. DOI: 10.1111/j.1349-7006.2010.01650.x. View

10.

Gajos-Michniewicz A, Czyz M . Role of miRNAs in Melanoma Metastasis. Cancers (Basel). 2019; 11(3). PMC: 6468614. DOI: 10.3390/cancers11030326. View

11.

Liu C, Hsieh C, Shen C, Lin C, Shigemura K, Sung S . Exosomes from the tumor microenvironment as reciprocal regulators that enhance prostate cancer progression. Int J Urol. 2016; 23(9):734-44. DOI: 10.1111/iju.13145. View

12.

Margolis L, Sadovsky Y . The biology of extracellular vesicles: The known unknowns. PLoS Biol. 2019; 17(7):e3000363. PMC: 6667152. DOI: 10.1371/journal.pbio.3000363. View

13.

Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom W . microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013; 8(9):1156-62. PMC: 4123222. DOI: 10.1097/JTO.0b013e318299ac32. View

14.

Clark D, Fondrie W, Yang A, Mao L . Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes. J Proteomics. 2016; 133:161-169. DOI: 10.1016/j.jprot.2015.12.023. View

15.

Gao F, Jiao F, Xia C, Zhao Y, Ying W, Xie Y . A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO. Chem Sci. 2019; 10(6):1579-1588. PMC: 6369439. DOI: 10.1039/c8sc04197k. View

16.

Jia G, Han Y, An Y, Ding Y, He C, Wang X . NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018; 178:302-316. DOI: 10.1016/j.biomaterials.2018.06.029. View

17.

Hood J, Wickline S . A systematic approach to exosome-based translational nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012; 4(4):458-67. DOI: 10.1002/wnan.1174. View

18.

Wu M, Ouyang Y, Wang Z, Zhang R, Huang P, Chen C . Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017; 114(40):10584-10589. PMC: 5635903. DOI: 10.1073/pnas.1709210114. View

19.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

20.

Chen B, Sung C, Chen C, Cheng C, Lin D, Huang C . Advances in exosomes technology. Clin Chim Acta. 2019; 493:14-19. DOI: 10.1016/j.cca.2019.02.021. View